Management Team

 

Stanley Lapidus, President, CEO and Founder

Stan is an experienced life-science entrepreneur and inventor with over 30 issued US patents. He founded and led Cytyc, EXACT Sciences and Helicos BioSciences (NASDAQ: CYTC, EXAS, HLCS). For over a decade, he has been teaching at MIT. From 2002 to 2012 Stan served as a trustee of Cooper Union, his alma mater. He was recently inducted into the College of Fellows of the American Institute of Medical and Biological Engineering.

Mark DePristo, Vice President of Informatics

Mark is an experienced innovator in the fields of computational biology and next generation sequencing. As a senior scientist at the Broad Institute of Harvard and MIT, he led the development of the Genome Analysis Toolkit (GATK), a software package used worldwide by prominent projects such as the 1000 Genomes Project. Mark is a Marshall Scholar and earned a PhD in Biochemistry from Cambridge University and a BA in Computer Science and Mathematics from Northwestern University.

Ute Geigenmüller, PhD, Vice President of Assay Development

Ute has experience in developing scalable systems for genome characterization and interpretation. After completing postdoctoral research in molecular genetics, she worked at Correlagen Diagnostics and Brigham and Women’s Hospital. Ute received her PhD in Biochemistry from the Freie Universität Berlin, Germany.

Bobbi Rathmell, MD, Vice President Clinical Operations

Bobbi has worked in biotech for the past 5 years at Seaside Therapeutics and Pfizer focused on improving the diagnosis and treatment of people affected by autism. Prior to working in industry she practiced general pediatrics, most recently at the University of Vermont.  She completed her MD and pediatric residency training at Wake Forest University. 

Bill Romeo, CFO

Bill has over 20 years of experience in executive leadership positions with responsibility for finance, strategic planning, business development, commercial operations, human resources and legal functions with established and emerging healthcare/life sciences companies. He has served as CFO of several private and public companies, including Humedica, NaviNet, Reprogenesis, and Alpha-Beta Technology.  Bill holds an undergraduate degree from Villanova University and an MBA from the University of Massachusetts and is a Certified Public Accountant.

Carla Sivak, RN, Vice President Quality and Regulatory

Carla has extensive experience in medical device quality and regulatory. She has held quality and regulatory leadership positions at Philips Healthcare, Edwards Lifesciences, Boston Scientific, Johnson & Johnson and CR Bard. Carla has a BS in Nursing from the UC San Francisco and an MS Computer Science from Fitchburg State University.  

Theresa Tribble, Vice President of Commercial Strategy

Theresa started her career at Putnam Associates, consulting to the pharmaceutical and medical device industries.  She graduated from Wellesley College and holds an MBA with Distinction from Harvard Business School.  She is a member of the Massachusetts Act Early Taskforce.